Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) closed the day trading at $4.78 down -1.24% from the previous closing price of $4.84. In other words, the price has decreased by -$1.24 from its previous closing price. On the day, 0.54 million shares were traded. VNDA stock price reached its highest trading level at $4.915 during the session, while it also had its lowest trading level at $4.75.
Ratios:
For a better understanding of VNDA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 4.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 31, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On July 11, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
Jefferies Downgraded its Buy to Hold on February 25, 2022, whereas the target price for the stock was revised from $24 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 14 ’24 when Mitchell Stephen Ray sold 5,000 shares for $5.17 per share. The transaction valued at 25,863 led to the insider holds 44,857 shares of the business.
Mitchell Stephen Ray bought 5,000 shares of VNDA for $27,000 on Nov 14 ’24. On Jul 29 ’24, another insider, Moran Kevin Patrick, who serves as the SVP, CFO & Treasurer of the company, sold 2,251 shares for $5.92 each. As a result, the insider received 13,327 and left with 228,763 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 282211200 and an Enterprise Value of -89608072. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.46 while its Price-to-Book (P/B) ratio in mrq is 0.51. Its current Enterprise Value per Revenue stands at -0.47 whereas that against EBITDA is 2.971.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $6.75, while it has fallen to a 52-week low of $3.46. The 50-Day Moving Average of the stock is -0.91%, while the 200-Day Moving Average is calculated to be -4.52%.
Shares Statistics:
Over the past 3-months, VNDA traded about 629.22K shares per day on average, while over the past 10 days, VNDA traded about 518540 shares per day. A total of 58.31M shares are outstanding, with a floating share count of 55.21M. Insiders hold about 5.31% of the company’s shares, while institutions hold 76.72% stake in the company. Shares short for VNDA as of 1731628800 were 3221519 with a Short Ratio of 5.12, compared to 1728950400 on 3978441. Therefore, it implies a Short% of Shares Outstanding of 3221519 and a Short% of Float of 6.68.
